This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Academy of Sciences. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations in Hematology: The Contributions of Hongling Wu
Introduction
Hongling Wu is a notable inventor based in Guangdong, China. She has made significant contributions to the field of hematology through her innovative research and patented methods. Her work focuses on improving the bone marrow microenvironment, which is crucial for the treatment of various hematologic disorders.
Latest Patents
Hongling Wu holds a patent for a method titled "Method for remolding bone marrow microenvironment." This invention discloses a technique for remolding the bone marrow microenvironment in subjects with impaired conditions. The method involves implanting a composition that includes isolated mesenchymal stromal cells (MSCs) into the bone marrow cavity. This innovative approach successfully restores normal hematopoiesis, inhibits the pathological processes associated with leukemia, and significantly prolongs survival periods. Furthermore, it is a safe and effective treatment for hematologic tumors such as leukemia and aplastic anemia, with no reported side effects.
Career Highlights
Hongling Wu is affiliated with the Chinese Academy of Sciences, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential to transform treatment protocols in hematology.
Collaborations
Hongling Wu collaborates with esteemed colleagues, including Tongjie Wang and Xiaofei Liu. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field.
Conclusion
Hongling Wu's innovative methods in remolding the bone marrow microenvironment represent a significant advancement in hematology. Her contributions have the potential to improve treatment outcomes for patients with hematologic disorders.